Pacira BioSciences, Inc. — All Filings
1,007 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
DEF 14A
DEFA14A
DFAN14A
EFFECT
FWP
REGDEX
REGDEX/A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-T
SC TO-T/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002087 | Mar 27, 2026 | — |
| 4/A | FORM 4/A | 0001628280-26-019892 | Mar 19, 2026 | Jun 11, 2025 |
| 4 | FORM 4 | 0001628280-26-019891 | Mar 19, 2026 | Mar 17, 2026 |
| 4 | FORM 4 | 0001628280-26-019890 | Mar 19, 2026 | Mar 17, 2026 |
| 144 | — | 0001959173-26-002422 | Mar 17, 2026 | — |
| 144 | — | 0001959173-26-002402 | Mar 17, 2026 | — |
| SCHEDULE 13D/A | — | 0001011438-26-000180 | Mar 12, 2026 | — |
| DFAN14A | — | 0001011438-26-000178 | Mar 12, 2026 | — |
| DEFA14A | DEFA14A | 0001628280-26-016906 | Mar 11, 2026 | — |
| DFAN14A | — | 0001011438-26-000176 | Mar 11, 2026 | — |
| S-8 | S-8 | 0001628280-26-012391 | Feb 26, 2026 | — |
| 10-K | 10-K - PCRX - 12.31.2025 | 0001628280-26-012297 | Feb 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001628280-26-012238 | Feb 26, 2026 | — |
| 4 | FORM 4 | 0001628280-26-008080 | Feb 13, 2026 | Feb 11, 2026 |
| 4 | FORM 4 | 0001628280-26-008078 | Feb 13, 2026 | Feb 11, 2026 |
| 4 | FORM 4 | 0001628280-26-008077 | Feb 13, 2026 | Feb 11, 2026 |
| 4 | FORM 4 | 0001628280-26-008076 | Feb 13, 2026 | Feb 11, 2026 |
| 4 | FORM 4 | 0001628280-26-008075 | Feb 13, 2026 | Feb 11, 2026 |
| 4 | FORM 4 | 0001628280-26-008074 | Feb 13, 2026 | Feb 11, 2026 |
| 4 | FORM 4 | 0001628280-26-005158 | Feb 3, 2026 | Jan 30, 2026 |
| 4 | FORM 4 | 0001628280-26-005157 | Feb 3, 2026 | Jan 30, 2026 |
| 4 | FORM 4 | 0001628280-26-005155 | Feb 3, 2026 | Jan 30, 2026 |
| 4 | FORM 4 | 0001628280-26-005154 | Feb 3, 2026 | Jan 30, 2026 |
| 4 | FORM 4 | 0001628280-26-005153 | Feb 3, 2026 | Jan 30, 2026 |
| 144 | — | 0001959173-26-000550 | Feb 2, 2026 | — |
| 144 | — | 0001959173-26-000513 | Feb 2, 2026 | — |
| 4 | FORM 4 | 0001628280-26-004188 | Jan 29, 2026 | Jan 27, 2026 |
| 3 | FORM 3 | 0001628280-26-004167 | Jan 29, 2026 | Jan 27, 2026 |
| 8-K | 8-K | 0001628280-26-003717 | Jan 28, 2026 | Jan 27, 2026 |
| DFAN14A | AMENDMENT NO. 1 | 0001214659-26-000291 | Jan 9, 2026 | — |
| 8-K | 8-K | 0001628280-26-001335 | Jan 8, 2026 | — |
| 4 | FORM 4 | 0001628280-26-000968 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0001628280-26-000967 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0001628280-26-000966 | Jan 6, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0001628280-26-000964 | Jan 6, 2026 | Dec 31, 2025 |
| 144 | — | 0001959173-26-000073 | Jan 5, 2026 | — |
| SCHEDULE 13D/A | — | 0001214659-26-000011 | Jan 2, 2026 | — |
| DFAN14A | — | 0001214659-25-018593 | Dec 30, 2025 | — |
| 4 | FORM 4 | 0001628280-25-056645 | Dec 11, 2025 | Dec 9, 2025 |
| 144 | — | 0001959173-25-007635 | Dec 10, 2025 | — |
| 144 | — | 0001959173-25-007602 | Dec 9, 2025 | — |
| 4 | FORM 4 | 0001628280-25-053205 | Nov 19, 2025 | Nov 17, 2025 |
| 144 | — | 0001959173-25-007033 | Nov 17, 2025 | — |
| 4 | FORM 4 | 0001628280-25-052038 | Nov 13, 2025 | Nov 10, 2025 |
| SCHEDULE 13G/A | — | 0001037389-25-000077 | Nov 13, 2025 | — |
| SCHEDULE 13D/A | — | 0001214659-25-016174 | Nov 10, 2025 | — |
| 144 | — | 0001959173-25-006826 | Nov 10, 2025 | — |
| 10-Q | 10-Q | 0001628280-25-050176 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001628280-25-050145 | Nov 6, 2025 | — |
| 4 | FORM 4 | 0001628280-25-048393 | Nov 3, 2025 | Oct 31, 2025 |